In conclusion, our in vitro and in vivo studies demonstrate that SOX4 regulates Fatty acid metabolism through ChREBP, thereby inhibiting ferroptosis and promoting angiogenesis and tumor growth in HCC. Here, MLXIPL is linked to hepatocellular carcinoma.